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A B S T R A C T
Decreased beta-amyloid clearance in Alzheimer’s disease and increased blood-brain barrier permeability in aged
subjects have been reported in several articles. However, morphological and functional characterization of
blood-brain barrier and its membrane transporter activity have not been described in physiological aging yet.
The aim of our study was to explore the structural changes in the brain microvessels and possible functional
alterations of P-glycoprotein at the blood-brain barrier with aging. Our approach included MR imaging for
anatomical orientation in middle aged rats, electronmicroscopy and immunohistochemistry to analyse the al-
terations at cellular level, dual or triple-probe microdialysis and SPECT to test P-glycoprotein functionality in
young and middle aged rats. Our results indicate that the thickness of basal lamina increases, the number of tight
junctions decreases and the size of astrocyte endfeet extends with advanced age. On the basis of microdialysis
and SPECT results the P-gp function is reduced in old rats. With our multiparametric approach a complex
regulation can be suggested which includes elements leading to increased permeability of blood-brain barrier by
enhanced paracellular and transcellular transport, and factors working against it. To verify the role of P-gp
pumps in brain aging further studies are warranted.
1. Introduction
Blood-brain barrier (BBB) dysfunction might be an important com-
ponent of many neurodegenerative disorders like Alzheimer’s disease
(Baloyannis, 2015; Miyakawa, 2010; Nelson et al., 2016; Zlokovic,
2011; Erdő et al., 2017), Parkinson’s disease (Cabezas et al., 2014; Gray
and Woulfe, 2015; Pisani et al., 2012; Erdő et al., 2017), stroke (Lucke-
Wold et al., 2014; Enciu et al., 2013; de Jong et al., 1990; Ronaldson
and Davis, 2012; Sandoval and Witt, 2008), pharmacoresistant epilepsy
(Ates et al., 1999; Michalak et al., 2012; Padou et al., 1995; Sahin et al.,
2003; Ndode-Ekane et al., 2010) and multiple sclerosis (Kamphuis
et al., 2015; McQuaid et al., 2009; Morgan et al., 2007; Alvarez et al.,
2011; Holman et al., 2011). Many of these diseases have an age-related
progression (Persidsky et al., 2006). However, in the process of healthy
aging there might also be an increased “leakage” of BBB not only by the
alteration of endothelial cells, thickness of basal lamina, and mor-
phology of pericytes and astrocytes (Peters et al., 1991), but also due to
the changes in expression of diﬀerent transporter proteins at the en-
dothelial cell layer of BBB. The aim of our study was therefore, to in-
vestigate the morphological and functional consequences of advanced
age on the blood-brain barrier during the process of physiological aging
in healthy rats. This study has a special focus on P-glycoprotein (P-gp,
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ABCB1/MDR1, Abcb1a/Mdr1a), (the most important eﬄux trans-
porter) functionality located on the luminal surface of brain capillary
endothelial cells. For this approach diﬀerent techniques were used such
as electronmicroscopy and immunohistochemistry for evaluation of
morphology and glial ﬁbrillar acidic protein (GFAP) and eﬄux trans-
porter protein expression; magnetic resonance imaging (MRI) to study
macroscopic anatomical alterations of the brain; brain and blood mi-
crodialysis to test eﬄux transporter functions and single photon emis-
sion computed tomography (SPECT) imaging also for investigation P-gp
eﬄux transporter functionality at the BBB.
2. Materials and methods
2.1. Comparative MRI in young adult and middle aged rats
MRI was performed on a 3T human MRI scanner (MAGNETOM Trio
a Tim System, Siemens AG, Erlangen, Germany) using a loop RF coil
with an inner diameter of 40mm (Siemens Medical Solutions, Erlangen,
Germany) and a custom-built head holder (Aradi et al., 2011). T2-
weighted images were obtained in three diﬀerent orientations (i.e.
axial, sagittal, coronal) using the following 2D turbo-spin echo se-
quence: TR/TE=5270/99ms; 26 slices; slice thickness= 1mm;
FOV=34×34mm2; matrix size= 192×192 interpolated to
384×384; bandwidth=40Hz/pixel; turbo factor= 8; averages= 2.
2.2. Immunohistochemistry
The rats were deeply anesthetized with a high dose of ketamine/
xylazine cocktail and transcardially perfused ﬁrst with physiological
saline (3min), then a ﬁxative containing 4% paraformaldehyde and
15% picric acid in 0.1 M phosphate buﬀer (PB) (30min).
60-μm-thick coronal sections were cut from the ﬁxed brain and
processed for immunostaining. The P-gp immunostaining was per-
formed according to Volk et al., (2005). In brief, the sections were pre-
treated with a mixture of 33% acetic acid and 66% ethanol (10min,
−20 °C), followed by the blocking of the endogenous peroxidase en-
zyme by 0.6% H2O2 (30min) and the blocking of the non-speciﬁc im-
munoglobulin binding of the tissue (60min) by a mixture of 3% Bovine
Serum Albumin (Sigma-Aldrich, St. Louis, MO, USA) and 10% NHS
(Normal Horse Serum, Vector Laboratories, Burlingame, CA, USA). The
GFAP-immunostaining protocol was performed as described by Grand
et al. (2010) with minor modiﬁcations (see below). These sections were
pre-treated by 1% H2O2, followed by a mixture of 2% NGS (Normal
Goat Serum, Vector Laboratories, Burlingame, CA, USA) and NHS.
A monoclonal mouse antibody against GFAP (1:2000, EMD
Millipore MAB3402, clone GA5, Billerica, MA, USA) or a monoclonal
mouse antibody against P-Glycoprotein (P-gp, 1 μg/ml, EMD Millipore
MAB517310, clone C219, Billerica, MA, USA) was used as a primary
antibody. For the visualization of immunopositive elements, biotiny-
lated anti-mouse immunoglobulin G (1:250, Vector Laboratories) was
applied as secondary serum, followed by avidin-biotinylated horse-
radish peroxidase complex (1:250, Vector Laboratories). The sections
were preincubated in 3,30-diaminobenzidine-tetrahydrochloride chro-
mogen (0.05%, Sigma-Aldrich) and then developed by 0.01% H2O2.
The P-gp-immunostained sections were mounted, dehydrated for light
microscopy (2×10min in xylene) and coverslipped with DePeX (Serva
Electrophoresis GmbH, Heidelberg, Germany). The GFAP-im-
munostained sections were osmicated (0.5%, Electron Microscopy
Sciences, Hatﬁeld, PA, USA), dehydrated in ethanol and mounted in
Durcupan (Sigma-Aldrich) for further light- and electron microscopic
examination. (For more details see: Grand et al., 2010).
2.3. Comparative electronmicroscopy of brain microvasculature of young
and middle aged rats
The electron microscopic examination of the blood brain barrier
was carried out on two animals (1 young and 1 old adult). The GFAP-
stained sections were used. A 400×400 μm2 region was re-embedded
from the striatum of both specimens under light microscopic control
and sectioned for electron microscopy. Ultrathin serial sections were
collected on Formvar-coated single slot grids, stained with lead citrate
and examined in a Hitachi 7100 electron microscope. Low- and high
magniﬁcation (1000×–30,000×) electron micrographs were taken of
the capillaries (n=7 and n= 5 in young- and old animals, respec-
tively).
2.4. Comparative investigation of P-gp function at the BBB in young adult
and middle aged rats by in vivo microdialysis
2.4.1. Animals, surgical procedures, and drug administration
Male Wistar rats (ToxiCoop, Budapest, Hungary) 2–3 months
(young adult) or 14–16 months (middle aged) were used throughout
the experiments and had free access to food and water. CMA/20 per-
ipheral probes were implanted in the jugular vein, and the rats were
then placed in a stereotaxic frame for implantation of CMA/12 brain
probes in the striatum (STR) or in the lateral ventricle (LV) for per-
forming the microdialysis experiments under chloral hydrate anesthesia
(400mg/kg, intraperitoneal) (Sziráki et al., 2011). The stereotaxic co-
ordinates for STR with respect to the bregma in young rats were
AP=+0.20mm, ML=+3.8, and DV=−7.4. In middle aged rats the
position for the STR probe was AP: +0.3mm, ML: +3.5mm and DV:
−7.5mm. An additional probe (CMA/12 1mm membrane) was placed
into the LV in the opposite hemisphere to the STR probe in middle aged
rats at AP:−1.0 mm, ML: +1.5, DV:−4.0 mm coordinates. Anesthesia
during the surgical procedures or the microdialysis experiments was
maintained by further injections of chloral hydrate as needed. Quini-
dine (Sigma-Hungary Kft, Budapest, Hungary, 5 mg/kg), the ABCB1
inhibitor PSC-833 (a gift from Prof. Gábor Tóth, University of Szeged,
Hungary, 2× 2mg/kg) and vehicle for the inhibitor were administered
intravenously (2 mL/kg bodyweight) via a catheter implanted in the
femoral vein. All animal experiments were performed in full com-
pliance with the guidelines of the Association for Assessment and Ac-
creditation of Laboratory Animal Care International’s expectations for
animal use, per the spirit of the licence issued by the Directorate for the
Safety of the Food Chain and Animal Health, Budapest and Pest County
Agricultural Administrative Authority, Hungary.
2.4.2. Microdialysis procedures and sampling
Animals were sampled from 60min before till 240min after in-
travenous (IV) dosing of quinidine. The peripheral and central probes
were perfused with artiﬁcial peripheral perfusion ﬂuid (aPPF) or arti-
ﬁcial cerebrospinal ﬂuid (aCSF) at a ﬂow rate of 1.0 μL/min using a
CMA 102 microdialysis pump. Samples were collected in polyethylene
microtubes and placed on dry ice at the end of each collection period.
After completing an experiment, the blood and brain dialysates were
transferred to a deep freezer and kept at −70 °C. Dialysate samples
were later transferred to a bioanalytical laboratory and analyzed for
concentrations of quinidine by LCMS–MS.
2.4.3. Data analysis of in vivo experiments
Unpaired Student’s t-test was performed on areas under the curve
(AUCs) of concentration-time proﬁles, maximum concentrations (Cmax
values), individual concentration values and brain-to-blood ratios for
testing possible age-dependent diﬀerences in concentrations of dialy-
sate samples by the advanced age. The statistical analysis was per-
formed by Microsoft Excel 2010.
At electromicroscopy the following parameters were examined: (i)
capillary wall thickness (as a ratio of the inner and outer perimeter of
the vessel); (ii) thickness of the basal membrane in spots of 0.5 μm
distance from each other along the outer perimeter (281 spots in young
and 259 spots in old adults); (iii) area of the astrocyte endfeet proﬁles
(normalized to area of the capillary wall); (iv) area of the pericyte
L. Bors et al. Brain Research Bulletin 139 (2018) 269–277
270
proﬁles (normalized to area of the capillary wall); (v) number and
length of the TJs (normalized to area of the capillary wall). For the
statistical analysis, the nonparametric Mann-Whitney U test was ap-
plied. Diﬀerences were considered to be signiﬁcant at probability va-
lues lower than 0.05.
2.5. LC–MS/MS for bioanalysis of dialysate samples
The quantitative analysis of the dialysate samples was performed on
Agilent 1100 HPLC system (Santa Clara, USA) coupled with Thermo
Scientiﬁc Q Exactive Plus orbitrap mass spectrometer (Waltham, MA
USA). The HPLC consisted of binary pump, thermostated autosampler
and thermostated column compartment. The column used was Kinetex
XB-C18 (particle size 2.6 μm, pore size 100 Å, length/diameter in mm:
50/2.1) from Phenomenex (Gen-Lab Kft., Budapest, Hungary). The
isocratic eluent was mixed by the HPLC pump at 0.5 mL/min ﬂow rate
in 92/8% A/B ratio where eluent A and B was MS grade water and
acetonitrile, respectively, both containing 0.1% formic acid (VWR
International Kft., Debrecen, Hungary). The analysis time was 2.5 min.
The mass spectrometer operated in positive PRM mode with HESI
source (spray voltage: 3500 V, capillary temperature: 300 °C, sheath
gas/auxiliary gas/spare gas: 55/15/5 in arbitrary units, sheath gas
temperature: 400 °C). The quantitation was done with the m/z:
79.0551 Da product ion with 5 ppm mass tolerance from the fragmen-
tation of the m/z: 325.1910 Da mass at HCD: 50.
The calibration samples were prepared by spiking aCSF solution in
1% with the working standards. The stock solution had 100mM con-
centration in DMSO, the working standards were diluted further in
DMSO in 0.025, 0.05, 0.25, 0.5, 2.5, 5, 25, 50, 250, 500 μM con-
centration. The ﬁnal concentration range of the calibration samples was
0.25–5000 nM.
2.6. Comparative investigation of P-gp function at the BBB by SPECT
imaging in young and middle aged rats
SPECT image acquisition was performed in a NanoSPECT/CT Silver
Upgrade system (Mediso, Budapest, Hungary) equipped with rat multi-
pinhole apertures. Rats (one young animal as baseline and another
young animal dosed with PSC833, one old animal as baseline and
another old animal dosed with PSC833) were injected intravenously
with [99mTechnetium]-2-methoxy-isobutyl-isonitrile (further referred
to as MIBI) with a mean activity of 166.89 MBq. The precursor (Medi-
MIBI kit, Medi-Radiopharma Ltd. Érd Hungary) was radiolabeled with
99mTc-pertechnetate from a 99mTc-generator (Elumatic III, cisbio in-
ternational, Gif-sur-Yvette, France) according to the manufacturer‘s
instructions. SPECT skull image acquisitions were started at 12, 24, 36,
48, 60, 72, 84, 96 108 and 120min post injection. The animal was
anaesthetized with 4% isoﬂurane in medical oxygene while anaesthesia
was maintained by 1.8% isoﬂurane inhalation. The animal was ﬁxed in
a Mediso MultiCell (Mediso, Budapest, Hungary) rat bed for exact po-
sitioning of the brain in the center of the SPECT ﬁeld of view. Each
SPECT 3D image acquisition took 10min with 30 raw data acquisition
steps. All ten three dimensional images of the skull region were re-
constructed using Mediso TeraTomo (Mediso, Budapest, Hungary)
SPECT Monte-Carlo simulation based iterative reconstruction algorithm
and radioactivity concentrations in MBq/mL were retrieved from the
whole brain as region of interest from every SPECT 3D image. Region of
interest (ROI) analysis and image processing was performed using the
VivoQuant software (inviCRO, Boston, US). Brain ROI radioactivity in
function of time and separately at the ﬁrst two timepoints was then
plotted for all scans using OriginPro 8 SR2. AUCs from timepoint 1
(12min) through to timepoint 10 (120min) were calculated for all 4
data sets using OriginPro 8 SR2.
3. Results
3.1. MR imaging
The axial, coronal and sagittal images of the brains of a young and a
middle aged animals were evaluated. A representative image from all
the three orientations are shown in Fig. 1. Comparing the size of the
brains, the anterior-posterior extension increased by 14.8%, the lateral
extension by 7.1% and the dorso-ventral extension by 14.4% with
aging. At the same time the diﬀerence between the bodyweights was
3.12 fold. The extension of cerebral ventricles increased signiﬁcantly
with aging which makes the placement of a third microdialysis probe
(beside the peripheral and striatal probes) possible exactly into the
lateral vetricle in middle aged rats. Due to thickening of the parietal
Fig. 1. MR imaging of the brain of a representative young adult and a middle aged Wistar rats. Coronal (A, B), sagittal (C, D) and also axial images (E, F) show a signiﬁcant diﬀerence in
the extension of the cerebral ventricles between the young (A, C, E) and middle aged (B, D, F) rats. The diﬀerence between the maximum dorso-ventral (DV), anterior-posterior (AP) and
lateral (LR) dimensions of the young and old brains are shown in panel G. The comparison of brain size, age and bodyweight of the two observed animals are displayed in panel H.
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skull bone, the lateral coordiantes of the striatal microdialysis probes
was modiﬁed in elderly animals from 3.8 to 3.5.
3.2. Light microscopy
P-gp plays an important role in the operation of the BBB by pumping
foreign substances out of the endothelial cells (Sarkadi et al., 2006).
Astroglial endfeet surrounding the brain capillaries contribute in the
functioning of the BBB by providing biochemical support to endothelial
cells (Abbott et al., 2006).
Therefore, after the in vivo experiments, we sacriﬁced the animals
and examined and compared the P-gp- and GFAP-staining in the young
and middle aged adults.
A moderate amount of astroglial cells and processes were visible in
the neocortex (not shown) and in the striatum (Fig. 2A) of the young
adult animals. In accordance with the literature (Middeldorp and Hol,
2011), both the amount of astroglial processes and their staining in-
tensity seemed to be increased in the middle aged rats (Fig. 2B).
The P-gp-staining conﬁned to blood vessels in the brain tissues. In
case of the young adult animals it was very intense, a high amount of
capillaries were immunopositive (Fig. 2C). As it is shown in Fig. 2D, the
staining intensity was considerably lower in case of the middle aged
Fig. 2. Light micrographs of the striatum of young adult and middle aged animals, showing astroglial- (A, B) and P-gp-immunostaining (C, D). A: In young adult animals a moderate
amount of astroglial elements are found in the striatum. B: In contrast, the astroglial-staining is considerably increased in the brain tissue of old animals. C: An intense staining of the P-gp
is visible in the striatum of young adult animals, indicating the high expression level of this eﬄux transporter protein in the endothelial cells. D: However, a remarkably decreased
expression level is found in case of the old animals. Scale: A, B: 200 μm; C, D: 250 μm.
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animals, suggesting a lower expression of this eﬄux transporter protein
by the increasing age (Silverberg et al., 2010).
3.3. Electronmicroscopy
The ultrastructural composition of the blood brain barrier was al-
tered in the old animal (Fig. 3).
The wall of the microvessels are composed of the regular elements,
such as the endothelial cells connected by tight junctions (TJ), pericytes
embedded in the basal membrane and the basal membrane which
bounds the capillary from the side of the brain parenchima. The ca-
pillaries were surrounded by GFAP-immunopositive astroglial endfeet.
The thickness of the capillary walls was calculated as a ratio of the
inner and outer perimeter of the vessel to avoid getting false results due
to measuring vessels of diﬀerent size. Values nearing 1 depict a thin
wall, whereas lower values depict a thicker wall. We found that the
thickness of the capillary walls was signiﬁcantly increased in the old
animal (0.88 ± 0.05 vs 0.57 ± 0.14 in young and middle aged adults,
respectively, p= 0.0058) (Fig. 3A, B).
The thickness of the basal membrane also increased signiﬁcantly in
case of the old animal (24.3 ± 8.8 nm vs 93.9 ± 34.1 nm in young
and middle aged adults, respectively, p= 0.0001) (Fig. 3C–F).
In the old animal, the area of the astrocyte endfeet proﬁles sur-
rounding the capillaries was signiﬁcantly higher, than in the young
animal (3.54 ± 3.42 μm2 vs 0.47 ± 1.06 μm2; p=0.0001). The dif-
ference was statistically signiﬁcant even after normalizing to the area of
the capillary wall (1.58 ± 1.14 vs 0.48 ± 0.65; p= 0.0348) (Fig. 3A,
B).
The amount of pericytes did not show any changes. The absolute
values of perycite proﬁle areas did not change (0.36 ± 0.41 μm2 in
young- and 0.54 ± 0.44 μm2 in old animal; p= 0.1012). Similarly the
values normalized to the area of the capillary wall (0.15 ± 0.04 vs
0.17 ± 0.07 in young and middle aged adults, respectively,
p= 0.5698) did not signiﬁcantly change.
Finally, we examined the tight junctions and found a decreased
amount between the endothelial cells in case of capillaries of the old
animal. The average length of the TJs did not show a diﬀerence in the
young and old animal (0.44 ± 0.35 μm vs 0.41 ± 0.51 μm;
p=0.4038). However, both the number of TJs (0.35 ± 0.29 vs
0.1 ± 0.2; p= 0.0740) and their total length per capillary
(0.11 ± 0.04 vs 0.04 ± 0.06; p= 0.0740) displayed a decreasing
tendency in the old animal (values are normalized to area of the ca-
pillary wall), although the diﬀerences were not signiﬁcant.
In summary, the ultrastructural composition of the blood brain
barrier changed in the old animal. The capillary walls and the basal
membranes were thicker, the size of astrocyte endfeet around the ves-
sels extended and the connection of endothelial cells by tight junctions
displayed a decreasing tendency.
3.4. LC–MS/MS results
For determination of quinidine concentration in dialysate samples
an LC–MS/MS method was developed. The calibration was accepted
with R2 value higher than 0.995. The calibration model was non-linear
due to the wide concentration range. The typical chromatograms are
shown in Fig. 4.
Fig. 3. Low- (A, B) and high magniﬁcation (C-F) electron micrographs of brain capillaries of young adult and middle aged animals. A: In case of the young adult animal, the capillary walls
are thin and are surrounded by astrocyte endfeet (ac). B: In case of the old animal, the capillary walls are thicker, and the extent of the astrocyte endfeet is considerably higher. C, E: A
segment of the capillary wall in young adult animal at a 30.000-fold magniﬁcation. A tight junction (TJ) is visible sealing the adjacent endothelial cells (e). On the opposite side of the
lumen, a pericyte (pc) can be observed embedded in the basal membrane (BM). D, F: A segment of the capillary wall in old animal at a 30.000-fold magniﬁcation. Smaller amount of tight
junctions are visible among the endothelial cells. The basal membrane is considerably thicker compared to young adult animal and like in the young specimens often surround pericytes.
Scale: A, B: 1 μm; C-F: 500 nm.
L. Bors et al. Brain Research Bulletin 139 (2018) 269–277
273
3.5. Microdialysis
The concentration-time proﬁles of quinidine in the striatum, in the
plasma and the lateral ventricle are shown in Fig. 5. The AUCSTR/
AUCblood ratio in control rats was 24.2% (young) and 29.6% (old), re-
spectively. The brain exposure was higher in middle aged animals than
in young ones in control groups (AUCSTR=124.82 vs 75.12 nM h), but
not in the PSC-833 treated groups (420.61 vs 530.96 nM h). In the
groups of P-gp inhibitor treated animals the AUCSTR/AUCblood ratio was
enhanced to 76.0% (young) and 91.0% (old), respectively. The striatal
concentrations of quinidine increased in a statistically signiﬁcant
manner both in young (p < 0.05) and in middle aged (p < 0.005) rats
after the administration of the inhibitor as it is seen from the AUCSTR
values (Fig. 5). Also the elimination of the drug from the brain and
blood shows a slower kinetics in the case of P-gp inhibition. The dif-
ference between the striatal concentration values of old and young
controls was statically signiﬁcant (p < 0.05) at later timepoints (120
and 150min after QND treatment) (Fig. 5A,C) reﬂecting to a higher,
and longer lasting exposure to P-gp substrate with advanced age. The
blood levels seemed also to be higher in aged than in the young
Fig. 4. LCMS-MS analysis of microdialysis samples. Calibration curve used for quantitation of dialysate samples (panel A). Typical chromatograms of the a) lowest calibration level
(0.25 nM), b) highest calibration level (5000 nM) and c) dialysate sample (panel B).
Fig. 5. Concentration-time proﬁles of quinidine (QND) (5mg/kg i.v.) in young (A, B) and middle aged (C, D) Wistar rats in absence (A,C) and presence (B,D) of PSC-833 (2x2mg/kg
i.v).The values are mean concentrations +/- SEM, N=3–5/group. *: p < 0.05, **:p < 0.005 by T-test (control group compared to PSC-833 treated group), p < 0.05 young controls
v.s. middle aged controls. STR: striatum, LV: lateral ventricle, AUC: area under the curve, QND: quinidine.
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subjects, but the diﬀerence was not statistically signiﬁcant.
The diﬀerent orientation of P-gp pump in the choroid plexus (blood
−cerebrospinal ﬂuid barrier, BSCFB) and in the BBB has been reported.
(Shen et al., 2009; Krajcsi et al., 2012) At the BCSFB the pumping
function of P-gp is oriented from the blood to the liquor, in contrast at
the BBB endothelial cells P-gp mediates the transport of its substrates
into the opposite direction, towards the blood. Therefore, we compared
the AUC ratio of quinidine for CSF (in the lateral ventricle) to blood and
for brain parenchyma (STR) to blood in presence and absence of PSC-
833 in the middle aged animals. The AUCLV/AUCblood showed a 2.03
fold increase and the AUCSTR/AUCblood displayed a 3.08 fold increase
after PSC-833 treatment (Fig. 5C,D). These data suggest that although
the orientation is diﬀerent there are other mechanisms too, playing a
role in quinidine disposition in the CNS.
In summary, our results indicate a moderate diﬀerence in the BBB
permeability between the young and old subjects for our P-gp substrate,
quinidine in control animals. However, if the transporter is chemically
blocked by a speciﬁc inhibitor the increase of brain exposure becomes
higher in young than in elderly subjects. These ﬁndings are in ac-
cordance with the lower expression level of P-gp in elderly animals (our
unpublished data) and reduced P-gp function reported in aged humans
(Toornvliet et al., 2006; Bartels et al., 2009). The blockade of lower
number of eﬄux transporter proteins results in a lower increase in the
BBB permeation for quinidine in old rats compared to the young adults.
3.6. SPECT imaging
The brain exposure to MIBI in presence and absence of P-gp in-
hibitor was evaluated in one-one representative animal by SPECT
imaging. The radioactivity in the brain increased both in young and in
old rats after administration of P-gp−inhibitor as it is seen in the MIBI
eﬄux curves (Fig. 6). At the ﬁrst timepoint the control exposure is
higher in young rats suggesting a slower kinetics, but after 24–36min
the MIBI level becomes higher in the brain of the middle aged animal
indicating a higher leakage of the BBB in the old subject. The order of P-
gp functionality in young and old animals is the following: young
control > old control > old PSC–833=young PSC-833 as it is seen in
Fig. 6. These results indicate a higher transcellular permeability of the
BBB endothelial cells for P-gp substrates in advanced age and a reduced
P-gp expression or function with aging leading to similar brain exposure
of MIBI to young subjects after chemical blocking of the transporter.
4. Discussion
Our study described here, focused on the investigation ofalteration
of the diﬀerent cerebrovascular parameters and factors with physiolo-
gical aging. Our model animals were male Wistar rats. They were
housed in pairs in their home cages. The keeping was at least 14–16
months long at our animal facility and during this period the animals
have ad libitum access to standard laboratory food and tap water.
According to the observations of Sengupta (2013), the age of the rats
can be correlated with the age of humans. In that study a comparison
between Rattus Norvegicus and humans was made. The study also ob-
served age-dependent correlations between the days of rat age and the
years of human age. Diﬀerent other methods of calculation for com-
paring the human and rat age have also been published. However, we
have not been able to identify any study on the comparison of diﬀerent
rat strains, although it is well known that the bodyweight and body size
development are very variable between diﬀerent rat strains. On the
basis of data available (Sengupta, 2013) we conclude that our experi-
mental rats were middle aged (approximately 50- year old in humans).
Our results conﬁrmed the data of the literature concerning the eﬀect
of aging on ultrastuctural changes in the brain microvasculature
(Hunziker et al., 1978; Kacem et al., 1998) and the GFAP and P-gp
expression in the BBB (Peinado et al., 1998; Tigges et al., 1995). On the
basis of these results our middle aged male Wistar rats seems to be
appropriate model animals of healthy, physiological aging. To char-
achterize the P-gp function relative to aging a previously validated
probe substrate, quinidine (ki et al., 2011, 2013;) was used in micro-
dialysis experiments and [99mTechnetium]-2-methoxy-isobutyl-iso-
nitrile (Tc-MIBI) (Piwnica-Worms and Sharma, 2010) was applied as a
SPECT radiotracer. Both compounds displayed a low brain exposure in
control animals and an enhanced brain level after P-gp inhibition. A
slower distribution of MIBI can be seen in aged animals then in young
ones in the ﬁrst some minutes after treatment (probably due to the
decreased blood ﬂow in aged rat), but 24min after the intravenous
injection a higher brain penetration was reached in the middle aged rat.
The brain exposure to MIBI is inﬂuenced by several factors like (i) re-
gional blood ﬂow (ii) cellular mitochondrial number per unit organ
mass (ii) cellular membrane potential (iii) mitochondrial membrane
potential (iv) cell membrane lipid bilayer ﬂuidity (v) cellular Na/H
antiporter activity and (vi) P-gp eﬄux pump expression and function
(Piwnica-Worms et al., 1990; Kurata et al., 2015). It has been described
that the cerebral blood ﬂow value is smaller in old subjects (Jeﬀerson
et al., 2017) than is young ones, therefore and due to an increased
thickness of the basal lamina and capillary walls (including cell mem-
brane thickness increase) and the astrocyte endfeet, MIBI inﬂow
slowers in old animals. In microdialysis study, the control level of
quinidine is higher in old than in young adult rats as it is seen from the
AUC values (Fig. 5A, C). However, these values are generated from a
240min period of time of concentration-time proﬁles which includes
the absorption, distribution and also the elimination phases of quini-
dine both in the brain parenchyma (STR) and in the cerebrospinal ﬂuid
(LV). The concentration diﬀerences are higher at the later timepoints
indicating a slower elimination in old rats.
Immunostainings, ultrastructural, microdialysis and SPECT results
taken together suggest that there are many remarkable diﬀerences in
the structure and function of the blood-brain barrier in young and old
rats. These diﬀerences can be detected at the level of endothelial cells,
astrocytes, tight junctions, basal membrane and eﬄux transporters.
Several structural and morphological alterations lead to a stronger
protection of the brain with aging, while other domains like P-gp
downregulation and lower expression of tight junction proteins result in
higher BBB permeability in aged subjects. The paracellular permeability
of BBB seems to be higher and the transcellular transport is increased
due to the reduced P-gp function with aging which can be a starting
point of the inﬂux of xenobiotics and diﬀerent dangerous endogenous
and exogenous compounds to the brain. To decide whether the
Fig. 6. Brain exposure to [99mTechnetium]-2-methoxy-isobutyl-isonitrile (MIBI) as
measured by radioactivity of the brain in 0-120min after intravenous administartion of
the tracer in young and middle aged animals treated or non-treated with PSC-833. Brain
radioactivity is expressed as a percent of the radioactivity detected in the brain in the ﬁrst
measuring period (0-12min).
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increasing BBB leakage initiate or enforce the serious events of age-
related neurodegenerative processes further studies are needed in ani-
mals with at an even more advanced age. Studies focusing on the
analysis of the changes in cognitive function and behavioral perfor-
mance of middle aged Wistar rats are warranted. Environmental factors
playing an important role in the eﬀect of aging on our mental health
should also be considered.These factors, such as the eﬀect of physical
activity, caloric restriction or cadmium intake of smokers should also be
taken into account and studied in details in the future.
Our present study has shed light on age-related diﬀerences in the
BBB and also pointed out the complexity of the topic.
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